Decrease of plasma and urinary oxidative metabolites of acetaminophen after consumption of watercress by human volunteers

Clinical Pharmacology and Therapeutics

Volumn 60, Issue 6, 1996, Pages 651-660

  Chen, Laishun ^a   Mohr, Sandra N ^a   Yang, Chung S ^a,b  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; PARACETAMOL;

ADULT; AEROBIC METABOLISM; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG STRUCTURE; DRUG URINE LEVEL; FEMALE; FOOD INTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; OXIDATION; PRIORITY JOURNAL;

ACETAMINOPHEN; ADMINISTRATION, ORAL; ADULT; ANTICARCINOGENIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; FEMALE; FOOD-DRUG INTERACTIONS; HUMANS; ISOTHIOCYANATES; LUNG NEOPLASMS; MALE; MIDDLE AGED; OXIDATION-REDUCTION; REFERENCE VALUES; VEGETABLES;

EID: 0030459242     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(96)90213-1     Document Type: Article

References (29)

1. Chung FL, Morse MA, Eklind KI. New potential chemopreventive agents for lung carcinogenesis of tobacco-specific nitrosamine. Cancer Res 1992; 52(suppl):2719S-23S.
2. Stoner GD, Morrissey DT, Heur YH, Daniel EM, Galati AJ, Wagner SA. Inhibitory effects of phenethyl isothiocyanate on N-nitrosobenzylmethylamine carcinogenesis in the rat esophagus. Cancer Res 1991;51: 2063-8.
3. Ishizaki H, Brady JF, Ning SM, Yang CS. Effect of phenethyl isothiocyanate on microsomal N-nitrosodimethylamine (NDMA) metabolism and other monooxygenase activities. Xenobiotica 1990;20:255-64.
4. Guo Z, Smith TJ, Thomas PE, Yang CS. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1butanone (NNK) by inducible and constitutive cytochrome P450 enzymes in rats. Arch Biochem Biophys 1992;298:279-86.
5. Yang CS, Yoo JSH, Ishizaki H, Hong JY. Cytochrome P450IIE1: roles in nitrosamine metabolism and mechanisms of regulation. Drug Metab Rev 1990; 22:147-60.
6. Nelson S. Metabolic activation and drug toxicity. J Med Chem 1982;25:753-65.
7. Corcoran GB, Mitchell JR, Vaishnav YN, Horning EC. Evidence that acetaminophen and N-hydroxy-acetaminophen form a common arylating intermediate, N-acetyl-p-benzoquinone imine. Mol Pharmacol 1980;18:536-42.
8. Dahlin DC, Miwa GT, Lu AYH, Nelson SD. N-Acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. Proc Natl Acad Sci USA 1984;81:1327-31.
9. Albano E, Rundgren M, Harvison PJ, Nelson DS, Moldéus P. Mechanisms of N-acetyl-p-benzoquinone imine cytotoxicity. Mol Pharmacol 1985; 28:306-11.
10. Boyd EM, Bereczky GM. Liver necrosis from paracetamol. Br J Pharmacol 1966;26:606-14.
11. Mitchell JR, Jollow DJ, Potter WZ, Davis DC, Gillette JR, Brodie BB. Acetaminophen-induced hepatic necrosis; I: role of drug metabolism. J Pharmacol Exp Ther 1973;187:185-94.
12. Jollow DJ, Mitchell JR, Potter WZ, Davis DC, Gillette JR, Brodie BB. Acetaminophen-induced hepatic necrosis; II: role of covalent binding in vivo. J Pharmacol Exp Ther 1973;187:195-202.
13. Roberts DW, Bucci TJ, Benson RW, Warbritton AR, McRae TA, Pumford NR, et al. Immunohistochemical localization and quantification of the 3-(cystein-S-yl)-acetaminophen protein adduct in acetaminophen hepatotoxicity. Am J Pathol 1991; 138:359-71.
14. Vermeulen NPE, Bessems JGM, Straat RVD. Molecular aspects of paracetamol-induced hepatotoxicity and its mechanism-based prevention. Drug Metab Rev 1992;24:367-407.
15. Raucy JL, Lasker JM, Lieber CS, Black M. Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2. Arch Biochem Biophys 1989;271:270-83.
16. Patten CJ, Thomas PE, Guy RL, Lee M, Gonzalez FJ, Guengerich FP, et al. Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem Res Toxicol 1993;6:511-8.
17. Thummel KE, Lee CA, Kunze KL, Nelson SD, Slattery JT. Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4. Biochem Pharmacol 1993;45:1563-9.
18. Jollow DJ, Thorgeirsson SS, Potter WZ, Hashimoto M, Mitchell JR. Acetaminophen-induced hepatic necrosis. Pharmacology 1974;12:251-71.
19. Yang CS, Smith T, Ishizaki H, Yoo JSH, Hong JY. Metabolism and activation of nitrosamines catalyzed by cytochrome P450 isozymes. In: Hlavica P, Damni LA, Gorrod JW, editors. N-Oxidation of drugs: biochemistry, pharmacology, and toxicology. New York: Chapman & Hall, 1991:295-311.
20. Tookey HL, VanEtten CH, Daxenbichler ME. Glucosinolates. In: Liener IE, ed. Toxic constituents of plant foodstuffs. New York: Academic Press, 1980: 103-42.
21. Chung FL, Morse MA, Eklind KI, Lewis J. Quatitation of human uptake of the anticarcinogen phenethyl isothiocyanate after a watercress meal. Cancer Epidemiol Biomarkers Prev 1992;1:383-8.
22. Yamaoke K, Nakagawa T, Uno T. Application of Akaike's Information Criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm 1978;6:165-75.
23. Schwartz G. Estimating the dimension of a model. Ann Stat 1978;6:461.
24. Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. New York: Marcel Dekker, 1982:1-46.
25. Eklind KI, Morse MA, Chung FL. Distribution and metabolism of the natural anticarcinogen phenethyl isothiocyanate in A/J mice. Carcinogenesis 1990;11: 2033-6.
26. Lesser PB, Vietti MM, Clark WD. Lethal enhancement of therapeutic doses of acetaminophen by alcohol. Dig Dis Sci 1986;31:103-5.
27. Seeff LB, Cuccherini BA, Zimmerman HJ, Adler E, Benjamin SB. Acetaminophen hepatotoxicity in alcoholics: a therapeutic misadventure. Ann Intern Med 1986;104:399-404.
28. Burk RF, Hill KE, Hunt RW Jr. Isoniazid potentiation of acetaminophen hepatotoxicity in the rat and 4-methylpyrazole inhibition of it. Res Commun Chem Pathol Pharmacol 1990;69:115-8.
29. Hecht SS, Chung FL, Richie JP Jr, Akerkar SA, Borukhova A, Skowronski L, et al. Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers. Cancer Epidemiol Biomarkers Prev 1995;4:885-93.